<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27388144</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9157</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of autoimmunity</Title><ISOAbbreviation>J Autoimmun</ISOAbbreviation></Journal><ArticleTitle>A Child's HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>201</StartPage><EndPage>207</EndPage><MedlinePgn>201-207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaut.2016.06.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-8411(16)30095-6</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) disproportionately affects women of reproductive age. During pregnancy, women are exposed to various sources of fetal material possibly constituting a significant immunologic exposure relevant to the development of SLE. The objective of this study was to investigate whether having any children who carry DRB1 alleles associated with SLE increase the risk of maternal SLE. This case-control study is based on the University of California, San Francisco Mother-Child Immunogenetic Study and from studies at the Inova Translational Medicine Institute. Analyses were conducted using data for 1304 mothers (219 cases/1085 controls) and their respective 1664 children. We selected alleles based on their known association with risk of SLE (DRB1*03:01, *15:01, or *08:01) or Epstein-Barr virus (EBV) glycoproteins (*04:01) due to the established EBV association with SLE risk. We used logistic regression models to estimate odds ratios (OR) and 95% confidence intervals (CI) for each allele of interest, taking into account maternal genotype and number of live births. We found an increase in risk of maternal SLE associated with exposure to children who inherited DRB1*04:01 from their father (OR 1.9; 95% CI, 1.1-3.2), among *04:01 allele-negative mothers. Increased risk was only present among mothers who were positive for one or more SLE risk-associated alleles (*03:01, *15:01 and/or *08:01). We did not find increased risk of maternal SLE associated with any other tested allele. These findings support the hypothesis that a child's alleles inherited from the father influence a mother's subsequent risk of SLE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>Giovanna I</ForeName><Initials>GI</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA 94720-3220, USA. Electronic address: gcruz@berkeley.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA 94720-3220, USA. Electronic address: xshao@berkeley.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quach</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA 94720-3220, USA. Electronic address: hquach@berkeley.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Kimberly A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94122, USA. Electronic address: ho.kimberly@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterba</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94122, USA. Electronic address: thesterbas@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noble</LastName><ForeName>Janelle A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Children's Hospital Oakland Research Institute, 5700 M.L.K. Jr. Way, Oakland, CA 94609, USA. Electronic address: jnoble@chori.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patsopoulos</LastName><ForeName>Nikolaos A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Medicine, Brigham &amp; Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA; Program in Translational Neuropsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham &amp; Women's Hospital, 75 Francis Street, Boston, MA 02115, USA; Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, 415 Main Street, Cambridge, MA 02142, USA. Electronic address: npatsopoulos@rics.bwh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118-4417, USA. Electronic address: mbusch@bloodsystems.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triulzi</LastName><ForeName>Darrell J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Institute for Transfusion Medicine, Department of Pathology, University of Pittsburgh, 3636 Blvd. of the Allies, Pittsburgh, PA 15213, USA. Electronic address: DTriulzi@itxm.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wendy S W</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Division of Medical Genomics, Inova Translational Medicine Institute, 8110 Gatehouse Road, Falls Church, VA 22042, USA. Electronic address: ShukwanWendy.Wong@inova.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Benjamin D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Division of Medical Genomics, Inova Translational Medicine Institute, 8110 Gatehouse Road, Falls Church, VA 22042, USA. Electronic address: Benjamin.Solomon@inova.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niederhuber</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Medical Genomics, Inova Translational Medicine Institute, 8110 Gatehouse Road, Falls Church, VA 22042, USA. Electronic address: John.Niederhuber@inova.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criswell</LastName><ForeName>Lindsey A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94122, USA. Electronic address: Lindsey.Criswell@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcellos</LastName><ForeName>Lisa F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA 94720-3220, USA; California Institute for Quantitative Biosciences (QB3), University of California Berkeley, 174 Stanley Hall, Berkeley, CA 94720-3220, USA. Electronic address: lbarcellos@berkeley.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI117879</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 AR053308</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR000079</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI059829</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AI116064</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Autoimmun</MedlineTA><NlmUniqueID>8812164</NlmUniqueID><ISSNLinking>0896-8411</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008431" MajorTopicYN="N">Maternal-Fetal Exchange</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Genetic epidemiology</Keyword><Keyword MajorTopicYN="N">Human leukocyte antigen genes</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27388144</ArticleId><ArticleId IdType="mid">NIHMS801123</ArticleId><ArticleId IdType="pmc">PMC5079818</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2016.06.017</ArticleId><ArticleId IdType="pii">S0896-8411(16)30095-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petri M. Epidemiology of systemic lupus erythematosus. Best practice &amp; research Clinical rheumatology. 2002;16:847&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12473278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JL. The otherness of self: microchimerism in health and disease. Trends in immunology. 2012;33:421&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3516290</ArticleId><ArticleId IdType="pubmed">22609148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis and rheumatism. 1996;39:191&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">8849367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kekow M, Barleben M, Drynda S, Jakubiczka S, Kekow J, Brune T. Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus. BMC musculoskeletal disorders. 2013;14:325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835618</ArticleId><ArticleId IdType="pubmed">24245522</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbud Filho M, Pavarino-Bertelli EC, Alvarenga MP, Fernandes IM, Toledo RA, Tajara EH, et al. Systemic lupus erythematosus and microchimerism in autoimmunity. Transplantation proceedings. 2002;34:2951&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">12431669</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol. 2007;178:5949&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">17442979</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M, Chamley LW. Placental extracellular vesicles and feto-maternal communication. Cold Spring Harb Perspect Med. 2015;5:a023028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4355256</ArticleId><ArticleId IdType="pubmed">25635060</ArticleId></ArticleIdList></Reference><Reference><Citation>Mincheva-Nilsson L, Baranov V. Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success. American journal of reproductive immunology (New York, NY : 1989) 2014;72:440&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">25164206</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">14561795</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapaa-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis research &amp; therapy. 2011;13:R30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241374</ArticleId><ArticleId IdType="pubmed">21342502</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando MM, Stevens CR, Sabeti PC, Walsh EC, McWhinnie AJ, Shah A, et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS genetics. 2007;3:e192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2065882</ArticleId><ArticleId IdType="pubmed">17997607</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcellos LF, May SL, Ramsay PP, Quach HL, Lane JA, Nititham J, et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS genetics. 2009;5:e1000696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758598</ArticleId><ArticleId IdType="pubmed">19851445</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, Taylor KE, Fernando MM, Nititham J, Alarcon-Riquelme ME, Barcellos LF, et al. Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am J Hum Genet. 2012;91:778&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3487133</ArticleId><ArticleId IdType="pubmed">23084292</ArticleId></ArticleIdList></Reference><Reference><Citation>McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nature medicine. 2005;11:85&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15619631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanlon P, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis research &amp; therapy. 2014;16:R3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3978841</ArticleId><ArticleId IdType="pubmed">24387619</ArticleId></ArticleIdList></Reference><Reference><Citation>Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A. 1989;86:5104&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC297565</ArticleId><ArticleId IdType="pubmed">2472638</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and rheumatism. 1997;40:1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and rheumatism. 1982;25:1271&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One. 2013;8:e64683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675122</ArticleId><ArticleId IdType="pubmed">23762245</ArticleId></ArticleIdList></Reference><Reference><Citation>Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics. 2003;164:1567&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1462648</ArticleId><ArticleId IdType="pubmed">12930761</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2081237</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RC. R: A Language and Environment for Statistical Computing. 2015</Citation></Reference><Reference><Citation>Doughty RW, Gelsthorpe K. Some parameters of lymphocyte antibody activity through pregnancy and further eluates of placental material. Tissue antigens. 1976;8:43&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">960074</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kampen CA, Versteeg-van der Voort Maarschalk MF, Langerak-Langerak J, van Beelen E, Roelen DL, Claas FH. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Human immunology. 2001;62:201&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11250037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouma GJ, van Caubergh P, van Bree SP, Castelli-Visser RM, Witvliet MD, van der Meer-Prins EM, et al. Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation. 1996;62:672&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8830835</ArticleId></ArticleIdList></Reference><Reference><Citation>Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod. 1991;6:294&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2056027</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeazzi M, Sebastiani GD, Tincani A, Piette JC, Allegri F, Morozzi G, et al. HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus. 2000;9:47&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">10715100</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ML, Arnett FC, Reveille JD. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis and rheumatism. 1993;36:94&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">7678744</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolen JS, Klippel JH, Penner E, Reichlin M, Steinberg AD, Chused TM, et al. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Annals of the rheumatic diseases. 1987;46:457&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1002164</ArticleId><ArticleId IdType="pubmed">3498447</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis and rheumatism. 2006;54:1117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">16572446</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Kim K, Han B, Pillai NE, Ong RT, Saw WY, et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Human molecular genetics. 2014;23:6916&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4245039</ArticleId><ArticleId IdType="pubmed">25070946</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Woude D, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Thomson W, Worthington J, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis and rheumatism. 2009;60:916&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">19333951</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006;39:63&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">16455583</ArticleId></ArticleIdList></Reference><Reference><Citation>Monneaux F, Muller S. Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis and rheumatism. 2002;46:1430&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12115171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1377040</ArticleId><ArticleId IdType="pubmed">9529358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartley JD, Ferguson BJ, Moffett A. The role of shed placental DNA in the systemic inflammatory syndrome of preeclampsia. Am J Obstet Gynecol. 2015;213:268&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">25794631</ArticleId></ArticleIdList></Reference><Reference><Citation>Buurma AJ, Penning ME, Prins F, Schutte JM, Bruijn JA, Wilhelmus S, et al. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung. Hypertension. 2013;62:608&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23817495</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotter AM, Martin CM, O'Leary J J, Daly SF. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. Am J Obstet Gynecol. 2004;191:515&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">15343229</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clinical journal of the American Society of Nephrology : CJASN. 2010;5:2060&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001786</ArticleId><ArticleId IdType="pubmed">20688887</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiby SE, Walker JJ, O'Shaughnessy K M, Redman CW, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. The Journal of experimental medicine. 2004;200:957&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2211839</ArticleId><ArticleId IdType="pubmed">15477349</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KL, McAlindon TE, Mulcahy E, Bianchi DW. Microchimerism in a female patient with systemic lupus erythematosus. Arthritis and rheumatism. 2001;44:2107&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">11592373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer Hovinga IC, Koopmans M, Baelde HJ, de Heer E, Bruijn JA, Bajema IM. Tissue chimerism in systemic lupus erythematosus is related to injury. Annals of the rheumatic diseases. 2007;66:1568&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2095333</ArticleId><ArticleId IdType="pubmed">17584805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer Hovinga IC, Koopmans M, Baelde HJ, van der Wal AM, Sijpkens YW, de Heer E, et al. Chimerism occurs twice as often in lupus nephritis as in normal kidneys. Arthritis and rheumatism. 2006;54:2944&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16948133</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004;292:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">15238593</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. Journal of autoimmunity. 2009;33:12&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19356902</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ. Causes. Am J Epidemiol. 1976;104:587&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">998606</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol. 1997;145:58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">8982023</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, et al. Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology. 1999;10:774&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10535796</ArticleId></ArticleIdList></Reference><Reference><Citation>Klonisch T, Drouin R. Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease. Trends Mol Med. 2009;15:510&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19828378</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloch EM, Reed WF, Lee TH, Montalvo L, Shiboski S, Custer B, et al. Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis. Chimerism. 2011;2:6&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3084949</ArticleId><ArticleId IdType="pubmed">21547029</ArticleId></ArticleIdList></Reference><Reference><Citation>George D, Czech J, John B, Yu M, Jennings LJ. Detection and quantification of chimerism by droplet digital PCR. Chimerism. 2013;4:102&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782543</ArticleId><ArticleId IdType="pubmed">23974275</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Annals of the rheumatic diseases. 2004;63:1155&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1755119</ArticleId><ArticleId IdType="pubmed">15308527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry. Arthritis &amp; rheumatology (Hoboken, NJ) 2014;66:357&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4617771</ArticleId><ArticleId IdType="pubmed">24504808</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers EC, Marder W, Cagnoli P, Lewis EE, DeGuire P, Gordon C, et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. Arthritis &amp; rheumatology (Hoboken, NJ) 2014;66:369&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4198147</ArticleId><ArticleId IdType="pubmed">24504809</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>